Top ▲
Target not currently curated in GtoImmuPdb
Target id: 1358
Nomenclature: CYP11A1
Abbreviated Name: Cholesterol side-chain cleavage enzyme
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 521 | 15q24.1 | CYP11A1 | cytochrome P450 family 11 subfamily A member 1 | |
Mouse | - | 526 | 9 31.63 cM | Cyp11a1 | cytochrome P450, family 11, subfamily a, polypeptide 1 | |
Rat | - | 526 | 8q24 | Cyp11a1 | cytochrome P450, family 11, subfamily a, polypeptide 1 |
Database Links | |
Alphafold | P05108 (Hs), Q9QZ82 (Mm), P14137 (Rn) |
BRENDA | 1.14.15.6 |
ChEMBL Target | CHEMBL2033 (Hs), CHEMBL5246 (Rn) |
Ensembl Gene | ENSG00000140459 (Hs), ENSMUSG00000032323 (Mm), ENSRNOG00000008074 (Rn) |
Entrez Gene | 1583 (Hs), 13070 (Mm), 29680 (Rn) |
Human Protein Atlas | ENSG00000140459 (Hs) |
KEGG Enzyme | 1.14.15.6 |
KEGG Gene | hsa:1583 (Hs), mmu:13070 (Mm), rno:29680 (Rn) |
OMIM | 118485 (Hs) |
Pharos | P05108 (Hs) |
UniProtKB | P05108 (Hs), Q9QZ82 (Mm), P14137 (Rn) |
Wikipedia | CYP11A1 (Hs) |
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific inhibitor tables |
Immuno Process Associations | ||
|
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||||
|
||||||||||||||
|
1. Browne LJ, Gude C, Rodriguez H, Steele RE, Bhatnager A. (1991) Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease. J Med Chem, 34 (2): 725-36. [PMID:1825337]
2. Lehmann TP, Wrzesiński T, Jagodziński PP. (2013) The effect of mitotane on viability, steroidogenesis and gene expression in NCI‑H295R adrenocortical cells. Mol Med Rep, 7 (3): 893-900. [PMID:23254310]
3. Libè R, Fratticci A, Bertherat J. (2007) Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer, 14 (1): 13-28. [PMID:17395972]
4. Rotstein DM, Kertesz DJ, Walker KA, Swinney DC. (1992) Stereoisomers of ketoconazole: preparation and biological activity. J Med Chem, 35 (15): 2818-25. [PMID:1495014]